TATA Health International Holdings Limited has scheduled a board meeting for 28 August 2026 in Hong Kong. Directors will review and approve the unaudited consolidated results for the six months ended 30 June 2026 and deliberate on the declaration of an interim dividend, if any. Additional routine business matters are also on the agenda.

As of the 17 August 2026 announcement date, the board comprises one executive director (Mr. Zhang Ming Qi), one non-executive director (Mr. Chen Qi) and four independent non-executive directors (Ms. Huang Lin, Mr. Li Liang, Mr. Du Jianfeng and Mr. Tan Kaiguo).